![PATTERN_ORANGE_1320x780_2](https://kcasbio.com/wp-content/uploads/2023/11/PATTERN_ORANGE_1320x780_2-900x900-c-default.webp)
Read article Common Rule – Who decides what happens to your samples?
The Department of Health and Human Services (HHS) has issued long awaited, comprehensive update on how medical research should be conducted. The Common Rule, 45 CFR 46 subpart A, issued 26 years ago and established basic protections for human subjects in research conducted by or supported by the HHS and…
![KCAS-blog-thumb_David-vs-Goliath](https://kcasbio.com/wp-content/uploads/2023/10/KCAS-blog-thumb_David-vs-Goliath-900x900-c-default.webp)
Read article Boutique CROs: Being David in a land of Goliaths
In today’s drug development arena, massive, multinational CROs dominate the industry. They offer a “one stop shop” suite of services covering Early Development to Phase IV Clinical Trials and everything in between. Although multinational…